drugset / Trial / NCT03822065
A Relative Bioavailability Food Effect Study of LY03005
RandomizedCrossoverOpen-labelTreatment
Summary
The objective if this study is to assess the relative bio-availability of single oral doses of 80 mg LY03005 tablets administered to healthy subjects under fed versus fasted conditions in a 2-period, crossover trial.
Timeline
- Start
- 2019-01-16
- Primary completion
- 2019-02-16
- Completion
- 2019-02-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Toludesvenlafaxine | Small molecule | 80 mg | Oral |